Results 161 to 170 of about 400,071 (226)

C3a targets the Hippo-YAP signaling pathway to promote Müller cells glial–mesenchymal transition in a high-glucose in vitro model

open access: yesEuropean Journal of Medical Research
Background Diabetic retinopathy (DR) is the most common microvascular complication of diabetes, severely affecting the health and quality of life of individuals with diabetes.
Shuang Liu   +6 more
doaj   +1 more source

Understanding Surface Interfacial Phenomena During Tricalcium Silicate Dissolution From TEM and XRR

open access: yesJournal of the American Ceramic Society, Volume 109, Issue 10, October 2026.
ABSTRACT Understanding the dissolution mechanism of tricalcium silicate (C3S) is essential for interpreting its reactivity in cementitious systems. While the dissolution mechanism of C3S has been considered to follow the classical leached‐layer model, the mechanism has also been proposed to occur through the coupled interfacial dissolution ...
Aidyn Tugelbayev   +5 more
wiley   +1 more source

Divergent roles of ent‐kaurene oxidase paralogs in rice momilactone biosynthesis

open access: yesJournal of Integrative Plant Biology, Volume 68, Issue 10, Page 3776-3789, October 2026.
Rice contains a five‐gene tandem array of genes encoding members of the ent‐kaurene oxidase (KO) family, with OsKOL4 and OsKOL5 playing divergent roles in momilactone metabolism, but both acting in the production of antifungal and antibacterial phytoalexins, which are important for disease resistance.
Zhibiao Wang   +8 more
wiley   +1 more source

Complement C3a receptor antagonism for ME/CFS neuroinflammation

open access: yes
Complement component 3a receptor (C3AR1) is activated by elevated C3a levels in ME/CFS patients, triggering microglial activation and neuroinflammation in brain regions controlling fatigue and cognitive function. C3AR1 antagonists like SB290157 or PMX205 could reduce complement-mediated neuroinflammation and improve central nervous system symptoms.
openaire   +2 more sources

Structural insights into agonist-binding and activation of the human complement C3a receptor

open access: yes, 2023
Yadav MK   +12 more
europepmc   +1 more source

Changes in complement C3a in the immunotherapy of advanced clear cell renal cell carcinoma. [PDF]

open access: yesTransl Androl Urol
Zhang C   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy